Health
WHO warns Afghanistan remains a hotspot for polio
The virus’s persistence in the region coupled with new detections in previously unaffected areas, has prompted concern over immunization gaps.
The World Health Organization (WHO) has raised alarm over the ongoing transmission of wild poliovirus type 1 (WPV1) in southern Afghanistan, warning that the region remains a major hotspot for the virus and poses a threat to global eradication goals.
In a new report issued after the 42nd meeting of the Polio IHR Emergency Committee, WHO confirmed that Afghanistan has reported one new WPV1 case and 30 positive environmental samples in 2025 so far.
While this marks a decline from 2024’s 25 cases, the virus’s persistence in the region coupled with new detections in previously unaffected areas, has prompted concern over immunization gaps.
The Committee noted that transmission in Afghanistan remains most intense in the southern cross-border corridor shared with Pakistan, particularly the Quetta Block and Helmand province. Meanwhile, the east region has shown improved immunity, with a decline in new detections.
Afghanistan has conducted two nationwide and two sub-national vaccination rounds this year, using a site-to-site strategy instead of traditional house-to-house campaigns, WHO reported.
The organization expressed concern that the current strategy fails to consistently reach all children—especially girls and the youngest—raising the risk of continued virus spread.
Ongoing population displacement, especially the return of undocumented Afghan migrants from Pakistan, is compounding the challenge, WHO stated adding that many returnees come from areas with low vaccination coverage.
WHO praised ongoing coordination between Afghan and Pakistani health officials and international partners, including vaccination at border crossings.
Globally, WPV1 remains endemic only in Afghanistan and Pakistan, but the risk of international spread persists, fueled by poor immunization, insecurity, and mobile populations.
Health
Polio cases in Afghanistan rise to six in 2026 as two new cases confirmed
According to the WHO, one of the newly confirmed cases was identified in Nari district of Kunar province, while the other was reported in Nahr-e-Siraj district of Helmand province.
The World Health Organization (WHO) has announced that the number of confirmed polio cases in Afghanistan has risen to six in 2026, following the detection of two new infections in the country.
According to the WHO, one of the newly confirmed cases was identified in Nari district of Kunar province, while the other was reported in Nahr-e-Siraj district of Helmand province. The organization also stated that 34 positive environmental samples of wild poliovirus have been recorded in Afghanistan so far this year.
The report adds that in 2025, a total of 52 wild poliovirus type 1 cases were confirmed across Afghanistan and Pakistan, including 21 cases in Afghanistan and 31 in Pakistan.
WHO further noted that in 2026 so far, nine wild poliovirus type 1 cases have been reported across both countries, with six in Afghanistan and three in Pakistan.
Health experts say that low public awareness, resistance from some families to vaccination campaigns, and limited access to remote areas remain key factors behind the continued spread of the disease.
They emphasize that polio is incurable and vaccination is the only effective way to prevent infection.
Public health specialists also stress the need to expand immunization coverage, particularly in hard-to-reach areas, and to strengthen public awareness campaigns, warning that eradication efforts will remain difficult without broad community cooperation.
Afghanistan and Pakistan remain the only two countries in the world where wild poliovirus is still endemic and has not been fully eradicated.
Health
Health ministry urges greater public participation in blood donation
The appeal was made on Saturday as health officials marked World Blood Donor Day, an annual event aimed at raising awareness about the importance of voluntary blood donation and recognizing the contribution of donors in saving lives.
Afghanistan’s Ministry of Public Health has called on citizens to increase their participation in blood donation campaigns, warning that many patients still struggle to obtain compatible blood in emergencies despite improvements in the country’s blood management system.
The appeal was made on Saturday as health officials marked World Blood Donor Day, an annual event aimed at raising awareness about the importance of voluntary blood donation and recognizing the contribution of donors in saving lives.
Speaking at the ceremony, officials highlighted the critical role blood donors play in supporting the healthcare system and ensuring that hospitals have adequate supplies for patients requiring urgent treatment.
Abdul Wali Haqqani, Deputy Minister for Health Services at the Ministry of Public Health, said that shortages in blood reserves continue to pose challenges for healthcare providers, particularly when patients require specific blood types.
“Unfortunately, patients who need blood do not always have immediate access to compatible negative blood groups,” Haqqani said. “Blood donation is a simple yet invaluable humanitarian act. The World Health Organization recommends that at least one percent of a country’s population donate blood regularly to maintain sufficient reserves.”
Haqqani stressed that increasing public participation in blood donation could significantly improve the availability of life-saving blood supplies and strengthen healthcare services across the country.
Meanwhile, Wahdat Alkozi, Director of Curative Medicine at the ministry, said Afghanistan has made notable progress in blood management in recent years. He noted that standardized blood separation and storage systems are now operating at the Central Blood Bank and several regional hospitals.
“We are working to expand these systems throughout the country so that patients can have greater access to safe and standardized blood services,” Alkozi said.
According to officials from the Central Blood Bank, more than 220,000 units of blood were collected from voluntary donors over the past year. The blood was used in the treatment of more than 250,000 patients nationwide, underscoring the growing demand for blood supplies in hospitals and healthcare facilities.
However, Niazgul Niazmand, head of the Central Blood Bank, said the shortage of negative blood groups remains a major challenge due to the limited number of donors with those blood types.
Health experts emphasize that blood donation not only helps save the lives of accident victims, surgical patients, mothers experiencing childbirth complications, and individuals suffering from serious illnesses, but can also benefit donors by promoting healthy blood circulation and stimulating the production of new blood cells.
World Blood Donor Day is observed every year on June 14 to encourage voluntary blood donation and raise awareness about the ongoing need for safe blood and blood products around the world.
Health
Afghanistan expands drug imports as Russian pharma company enters market
Russian pharmaceutical manufacturer Pharmasyntez is preparing to enter the Afghan market after reaching an agreement with Afghanistan’s Ministry of Public Health to begin supplying medicines to the country, as Kabul faces growing challenges in securing reliable drug imports.
The company said the first shipments are expected to arrive within the next two months, with supplies expected to include insulin, antibiotics, and medicines for cardiovascular diseases and cancer — products that Afghan health authorities say are in high demand.
Afghanistan relies heavily on imported medicines, with most pharmaceutical supplies traditionally coming from Pakistan, Iran, India, and Middle Eastern countries.
However, industry analysts say recent tensions between Afghanistan and Pakistan have disrupted some supply chains, creating shortages and opening opportunities for new suppliers.
Pharmasyntez said it decided to enter Afghanistan because of the country’s limited access to quality medicines.
The company’s portfolio includes more than 300 pharmaceutical products manufactured across seven production facilities in Russia.
Founded in 1997 in Irkutsk by businessman Vikram Punia, the company currently exports mainly to Kazakhstan, Uzbekistan, and Belarus, while also operating in markets including Myanmar and the Dominican Republic.
According to publicly available information, Pharmasyntez is the first major Russian pharmaceutical company to formally target the Afghan market.
Trade relations between Afghanistan and Russia have expanded in recent years, with Afghanistan’s Ministry of Industry and Trade reporting annual bilateral trade of around $538 million.
Russia currently exports wheat, flour, fuel products, timber, and sunflower oil to Afghanistan.
The last known Russian medicine deliveries to Afghanistan were humanitarian aid shipments sent after the deadly earthquakes that struck Herat province in 2023.
-
Latest News4 days agoTAPI project advances in Afghanistan as 84kms of pipeline laid
-
International Sports5 days agoWorld Cup 2026: Havertz, Ayari and Balogun lead Golden Boot standings
-
Regional5 days agoGlobal leaders react to announcement of US-Iran peace agreement
-
Latest News4 days agoEU, Central Asian representatives meet in Kazakhstan to discuss Afghanistan cooperation
-
Latest News4 days agoAfghanistan to host regional meeting of strategic research centers in Kabul
-
Business1 day agoAfghanistan signs $67 million contract for cement production in Samangan
-
Sport2 days ago2nd ODI: India crush Afghanistan by 170 runs to seal series lead
-
Latest News5 days agoPeshawar economy under pressure amid ongoing crossing closures
